These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 8781354)

  • 61. Survival and recurrence rates after resection for hepatocellular carcinoma in noncirrhotic livers.
    Lang H; Sotiropoulos GC; Brokalaki EI; Schmitz KJ; Bertona C; Meyer G; Frilling A; Paul A; Malagó M; Broelsch CE
    J Am Coll Surg; 2007 Jul; 205(1):27-36. PubMed ID: 17617329
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Unusual spread of primary liver cancer (1 case)].
    Prikhod'ko NT
    Vopr Onkol; 1972; 18(8):84-6. PubMed ID: 4348593
    [No Abstract]   [Full Text] [Related]  

  • 63. Origin of hepatocellular carcinoma recurring after allotransplantation revealed by microsatellite analysis.
    Pfeiffer H; Ortmann C; Klein A; Brinkmann B
    J Clin Pathol; 1997 Sep; 50(9):792-4. PubMed ID: 9389984
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Molecular markers predicting outcome in hepatocellular carcinoma treated by liver transplantation.
    Llovet JM
    Liver Transpl; 2015 Nov; 21 Suppl 1():S25-6. PubMed ID: 26335803
    [No Abstract]   [Full Text] [Related]  

  • 65. Experimental and clinical study on hepatobiliary surgery in China.
    Wu M
    Chin Med J (Engl); 1996 Feb; 109(2):131-3. PubMed ID: 8758337
    [No Abstract]   [Full Text] [Related]  

  • 66. A primer on a hepatocellular carcinoma bioresource bank using the cancer genome atlas guidelines: practical issues and pitfalls.
    Nguyen NT; Cotton RT; Harring TR; Guiteau JJ; Gingras MC; Wheeler DA; O'Mahony CA; Gibbs RA; Brunicardi FC; Goss JA
    World J Surg; 2011 Aug; 35(8):1732-7. PubMed ID: 21221581
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Hepatoma with recurrence and amyloidosis].
    DELRIO JM; GUASTAVINO GN
    Bol Trab Soc Cir B Aires; 1953 Nov; 37(25):625-36; discussion, 637-8. PubMed ID: 13115536
    [No Abstract]   [Full Text] [Related]  

  • 68. Role of ncRNAs in Hepatocellular Carcinoma.
    Tu K; Dong Q; Tao J
    Biomed Res Int; 2018; 2018():3014543. PubMed ID: 30151377
    [No Abstract]   [Full Text] [Related]  

  • 69. A Dive Into the Deep Heterogeneity of Hepatocellular Carcinoma.
    Caruso S; Nault JC
    Gastroenterology; 2019 Dec; 157(6):1477-1479. PubMed ID: 31606468
    [No Abstract]   [Full Text] [Related]  

  • 70. Spleen in hepatocellular carcinoma: More complexity and importance than we knew.
    Wei W; Li L; Kong G; Zheng Z; Ji F; Li Z
    J Hepatol; 2019 Apr; 70(4):805-806. PubMed ID: 30683601
    [No Abstract]   [Full Text] [Related]  

  • 71. Hepatocellular Carcinoma - Origins and Outcomes.
    Kelley RK; Greten TF
    N Engl J Med; 2021 Jul; 385(3):280-282. PubMed ID: 34260842
    [No Abstract]   [Full Text] [Related]  

  • 72. Reply to A. Braillon.
    Yuan Y; Li B; Qiu J
    J Clin Oncol; 2017 Jun; 35(18):2098-2099. PubMed ID: 28398849
    [No Abstract]   [Full Text] [Related]  

  • 73. Prognosis after intrahepatic recurrence in the patients who underwent curative resection for hepatocellular carcinoma.
    Lee J; Cho EH; Kim SB; Kim R
    Ann Hepatobiliary Pancreat Surg; 2020 Nov; 24(4):431-436. PubMed ID: 33234745
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular tools and hepatocellular carcinoma: Adding help or confusion in liver transplantation?
    Vibert E; Samuel D
    J Hepatol; 2008 Oct; 49(4):498-501. PubMed ID: 18678433
    [No Abstract]   [Full Text] [Related]  

  • 75. Flow cytometric DNA analysis of cirrhotic liver cells in patients with hepatocellular carcinoma can provide a new prognostic factor.
    Ruà S; Comino A; Fruttero A; Torchio P; Bouzari H; Taraglio S; Torchio B; Capussotti L
    Cancer; 1996 Sep; 78(6):1195-202. PubMed ID: 8826940
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recurrence of hepatocellular carcinoma after liver transplantation: is immunosuppression a factor?
    Schwartz M; Konstadoulakis M; Roayaie S
    Liver Transpl; 2005 May; 11(5):494-6. PubMed ID: 15838915
    [No Abstract]   [Full Text] [Related]  

  • 77. Recurrence of hepatocellular carcinoma after surgery: can it be avoided?
    Kew MC
    Hepatology; 1996 Sep; 24(3):741-2. PubMed ID: 8781354
    [No Abstract]   [Full Text] [Related]  

  • 78. Loss of heterozygosity at D14S62 and D14S51 detected by a simple and non-radioactive method in plasma DNA is a potential marker of metastasis and recurrence after curative hepatic resection in hepatocellular carcinoma.
    Niu Q; Tang ZY; Qin LX; Ma ZC; Zhang LH
    Hepatogastroenterology; 2003; 50(53):1579-82. PubMed ID: 14571790
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.